Bank of New York Mellon’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-146,081
| Closed | -$2.43M | – | 4441 |
|
|
2017
Q3 | $2.43M | Sell |
146,081
-43,418
| -23% | -$706K | ﹤0.01% | 2723 |
|
|
2017
Q2 | $3.39M | Buy |
189,499
+9,245
| +5% | +$173K | ﹤0.01% | 2530 |
|
|
2017
Q1 | $3.61M | Buy |
180,254
+4,596
| +3% | +$107K | ﹤0.01% | 2501 |
|
|
2016
Q4 | $4.4M | Buy |
175,658
+60,335
| +52% | +$1.43M | ﹤0.01% | 2385 |
|
|
2016
Q3 | $2.69M | Buy |
115,323
+2,892
| +3% | +$68K | ﹤0.01% | 2578 |
|
|
2016
Q2 | $2.25M | Sell |
112,431
-13,519
| -11% | -$252K | ﹤0.01% | 2645 |
|
|
2016
Q1 | $2.13M | Buy |
125,950
+4,002
| +3% | +$82K | ﹤0.01% | 2622 |
|
|
2015
Q4 | $2.71M | Sell |
121,948
-790
| -0.6% | -$16.4K | ﹤0.01% | 2533 |
|
|
2015
Q3 | $2.08M | Sell |
122,738
-29,361
| -19% | -$457K | ﹤0.01% | 2719 |
|
|
2015
Q2 | $2.09M | Buy |
152,099
+5,567
| +4% | +$74K | ﹤0.01% | 2887 |
|
|
2015
Q1 | $2.01M | Buy |
146,532
+8,698
| +6% | +$100K | ﹤0.01% | 2862 |
|
|
2014
Q4 | $1.46M | Sell |
137,834
-6,209
| -4% | -$73.5K | ﹤0.01% | 3063 |
|
|
2014
Q3 | $1.8M | Buy |
144,043
+9,517
| +7% | +$133K | ﹤0.01% | 2949 |
|
|
2014
Q2 | $1.84M | Buy |
134,526
+2,653
| +2% | +$34.7K | ﹤0.01% | 2951 |
|
|
2014
Q1 | $1.59M | Buy |
131,873
+2,887
| +2% | +$33.1K | ﹤0.01% | 3030 |
|
|
2013
Q4 | $1.58M | Buy |
128,986
+3,769
| +3% | +$44.2K | ﹤0.01% | 3033 |
|
|
2013
Q3 | $1.27M | Sell |
125,217
-6,392
| -5% | -$59.8K | ﹤0.01% | 3100 |
|
|
2013
Q2 | $1.18M | Buy |
+131,609
| New | +$1.33M | ﹤0.01% | 3096 |
|
Bank of New York Mellon's OME Position: Q4 2017 in Review
Bank of New York Mellon sold out of Omega Protein (OME) in Q4 2017, closing a stake of 146,081 shares — an estimated $2.43M sold.
Bank of New York Mellon first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $4.4M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Bank of New York Mellon reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Bank of New York Mellon sold 146,081 Omega Protein shares in Q4 2017, an estimated $2.43M.
- Bank of New York Mellon first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Bank of New York Mellon's Omega Protein position peaked at $4.4M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Bank of New York Mellon's 13F filing for Q4 2017, filed 9 Feb 2018.